DavidMichaelSteinhausMD
Cardiology • Minneapolis, MNAdult Congenital Heart Disease, Cardiac Electrophysiology
Vice President Medtronic
Dr. Steinhaus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Park Ave
Minneapolis, MN 55415Phone+1 763-514-3577
Education & Training
Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 1983 - 1984- Massachusetts General HospitalFellowship, Cardiovascular Disease, 1980 - 1983
- Massachusetts General HospitalResidency, Internal Medicine, 1977 - 1980
Harvard Medical SchoolClass of 1977
Certifications & Licensure
KS State Medical License 1996 - 2025
MN State Medical License 2006 - 2025
MO State Medical License 1984 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- AdaptResponse Clinical Trial Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- 98 citationsEffect of chronic right ventricular apical pacing on left ventricular function.James H. O'Keefe, Hussam Abuissa, Philip G. Jones, Randall C. Thompson, Timothy M. Bateman
The American Journal of Cardiology. 2005-03-15 - 43 citationsOptimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging.Wolfgang Schoels, David Steinhaus, W. Ben Johnson, Gilles O'Hara, Joerg O. Schwab
Heart Rhythm. 2007-07-01 - 31 citationsImplant Experience with an Implantable Hemodynamic Monitor for the Management of Symptomatic Heart FailureDavid M. Steinhaus, Dwight W. Reynolds, Fredrik Gadler, G. Neal Kay, Mike F. Hess
Pacing and Clinical Electrophysiology. 2005-08-01
Press Mentions
Medtronic’s Implantable System for Remodulin to Treat Patients with Pulmonary Arterial Hypertension Gets FDA ApprovalAugust 9th, 2018
FDA Approves Medtronic’s Implantable System for Remodulin to Treat PAHAugust 1st, 2018
Medtronic, United Receive Approval for Fully Implantable PAH Infusion PumpAugust 1st, 2018- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
